Holly M. Horton

Enhanced antibody half-life improves in vivo activity

Jonathan Zalevsky, Aaron K. Chamberlain, Holly M. Horton et al. · Nature Biotechnology · 2010 · 644 citations · Full text

Pharmacy, Immunology, Pharmacokinetics +12

Potent <i>In vitro</i> and <i>In vivo</i> Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia

Holly M. Horton, Matthew J. Bernett, Erik Pong et al. · Cancer Research · 2008 · 271 citations · Full text

Pharmacy, Immunology, Oncology +17

Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells

Kevin M. Friedman, Tracy E. Garrett, John Evans et al. · Human Gene Therapy · 2018 · 207 citations · Full text

Medicine, Cancer Biology, Oncology +17

Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

Patrick A. Baeuerle, Jian Ding, Ekta Patel et al. · Nature Communications · 2019 · 203 citations · Full text

Life Sciences, Immunology, Oncology +17

Saturable attachment sites for polyhedron-derived baculovirus on insect cells and evidence for entry via direct membrane fusion

Holly M. Horton, John P. Burand · Journal of Virology · 1993 · 153 citations · Full text

Life Sciences, Entomology, Molecular Biology +17